BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. (Q48551095)

12 February 2018

title

BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. (English)

1 reference

12 February 2018

1 reference

1 reference

1 reference

Morimoto K

1

1 reference

12 February 2018

Sato H

2

1 reference

12 February 2018

Sato K

3

1 reference

12 February 2018

Sato S

4

1 reference

12 February 2018

Yamada N

5

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

European Journal of Pharmacology

published in

1 reference

12 February 2018

volume

339

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

11-15

1 reference

12 February 2018

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Antiepileptic drug mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Kindling-induced changes in EEG recorded during stimulation from the site of stimulation. III. Direct pharmacological manipulations of the kindled amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Modification of seizure activity by electrical stimulation. II. Motor seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Kindling: basic mechanisms and clinical validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901347-2

10.1016/S0014-2999(97)01347-2

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9450611

1 reference

12 February 2018